A new trading day began on Tuesday, with Revolution Medicines Inc (NASDAQ: RVMD) stock price up 0.43% from the previous day of trading, before settling in for the closing price of $42.14. RVMD’s price has ranged from $27.80 to $62.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -23.15%. Meanwhile, its annual earnings per share averaged 10.03%. With a float of $154.04 million, this company’s outstanding shares have now reached $167.75 million.
Let’s determine the extent of company efficiency that accounts for 378 employees. In terms of profitability, gross margin is -17912.67%, operating margin of -88031.94%, and the pretax margin is -76377.09%.
Revolution Medicines Inc (RVMD) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Revolution Medicines Inc is 15.52%, while institutional ownership is 82.12%. The most recent insider transaction that took place on Jan 21 ’25, was worth 97,443. In this transaction General Counsel of this company sold 2,406 shares at a rate of $40.50, taking the stock ownership to the 39,222 shares. Before that another transaction happened on Jan 21 ’25, when Company’s Officer proposed sale 2,406 for $40.29, making the entire transaction worth $96,938.
Revolution Medicines Inc (RVMD) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.94 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.74% during the next five years compared to -36.05% drop over the previous five years of trading.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Here are Revolution Medicines Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 14.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10428.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.59, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -3.96 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Looking closely at Revolution Medicines Inc (NASDAQ: RVMD), its last 5-days average volume was 1.06 million, which is a drop from its year-to-date volume of 1.35 million. As of the previous 9 days, the stock’s Stochastic %D was 63.25%. Additionally, its Average True Range was 1.61.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 12.85%, which indicates a significant decrease from 63.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 24.30% in the past 14 days, which was lower than the 43.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $45.67, while its 200-day Moving Average is $44.27. However, in the short run, Revolution Medicines Inc’s stock first resistance to watch stands at $42.73. Second resistance stands at $43.13. The third major resistance level sits at $43.62. If the price goes on to break the first support level at $41.84, it is likely to go to the next support level at $41.35. Now, if the price goes above the second support level, the third support stands at $40.95.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
With a market capitalization of 7.72 billion, the company has a total of 168,219K Shares Outstanding. Currently, annual sales are 11,580 K while annual income is -436,370 K. The company’s previous quarter sales were 0 K while its latest quarter income was -156,290 K.
